03.05.25 -- How To Optimize Downstream Separation With Tagless Proteins

As the biopharmaceutical market continues to grow, explore the barriers facing manufacturers and how to best evaluate a drug substance's characteristics and determine the most appropriate delivery device.

Explore market trends that could impact the lifecycle strategies for your drug product and its packaging. Careful selection of drug packaging can save time and support a successful transition to new formats.

Bulk filling drug substances is a lengthy, manual process of adjusting pump controls to achieve accurate filling. This method increases process risk through errors that can compromise accuracy.

Learn about the advantages of an optimal packaging design and the resulting benefits of its implementation to the overall process.

Explore important initial steps to consider and implement during the process design phase which is a pre-requisite to a successful PPQ campaign and readiness for commercial manufacturing.

Get insights from process developers working with recombinant proteins that cannot be purified with affinity chromatography.

Orphan drug development is a journey marked by challenges at every step. From patient recruitment to aseptic fill finish, overcoming hurdles is critical for bringing life-saving treatments to market.

Biomanufacturing leaders unite to optimize exosome/EV production. Explore their combined upstream/downstream approach for optimized cell culture, purification, and quality control.

Explore results from a study demonstrating comparability in product quality and chromatographic process characteristics between a Protein A affinity capture membrane and a packed-bed resin reference.

Examine the throughput performance of sterilizing grade filters across moderate-to-high concentrations of mAbs and immunoglobulins as well as how filter selection can impact your process.